Cue Biopharma, Inc.盘中异动急速上涨5.04%

市场透视2025-07-08

北京时间2025年07月08日23时39分，Cue Biopharma, Inc.（CUE.us）股票出现异动，股价大幅上涨5.04%。截至发稿，该股报0.736美元/股，成交量3.3591万股，换手率0.04%，振幅8.43%。最近的财报数据显示，该股实现营业收入421000.00美元，净利润-12.26百万美元，每股收益-0.17美元，毛利-460000.00美元，市盈率-1.13倍。机构评级...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2549529294?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-08 23:39","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2549529294","market":"us","top_or_hot":-1,"title":"Cue Biopharma, Inc.盘中异动 急速上涨5.04%","media":"市场透视","content":"<div>\n<p>北京时间2025年07月08日23时39分，Cue Biopharma, Inc.（CUE.us）股票出现异动，股价大幅上涨5.04%。截至发稿，该股报0.736美元/股，成交量3.3591万股，换手率0.04%，振幅8.43%。最近的财报数据显示，该股实现营业收入421000.00美元，净利润-12.26百万美元，每股收益-0.17美元，毛利-460000.00美元，市盈率-1.13倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708233921979e8188&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cue Biopharma, Inc.盘中异动 急速上涨5.04%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCue Biopharma, Inc.盘中异动 急速上涨5.04%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-08 23:39 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708233921979e8188&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年07月08日23时39分，Cue Biopharma, Inc.（CUE.us）股票出现异动，股价大幅上涨5.04%。截至发稿，该股报0.736美元/股，成交量3.3591万股，换手率0.04%，振幅8.43%。最近的财报数据显示，该股实现营业收入421000.00美元，净利润-12.26百万美元，每股收益-0.17美元，毛利-460000.00美元，市盈率-1.13倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708233921979e8188&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CUE","symbol_name":"Cue Biopharma, Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708233921979e8188&s=b","article_id":"2549529294","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708233921979e8188&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2549529294","pubTimestamp":1751989160,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年07月08日23时39分，Cue Biopharma, Inc.股票出现异动，股价大幅上涨5.04%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.19%。其相关个股中，Zyversa Therapeutics, Inc.、Rallybio Corporation、Seastar Medical Holding Corporation涨幅较大，Zyversa Therapeutics, Inc.、Moleculin Biotech, Inc.、Rallybio Corporation较为活跃，换手率分别为2051.25%、558.05%、304.18%，振幅较大的相关个股有Zyversa Therapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为87.67%、73.34%、70.96%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段的生物制药公司。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"CUE":"Cue Biopharma, Inc.","BK4139":"生物科技"},"translate_title":"Cue Biopharma, Inc. surged 5.04% in intraday movements","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CUE":1},"content_text":"北京时间2025年07月08日23时39分，Cue Biopharma, Inc.（CUE.us）股票出现异动，股价大幅上涨5.04%。截至发稿，该股报0.736美元/股，成交量3.3591万股，换手率0.04%，振幅8.43%。最近的财报数据显示，该股实现营业收入421000.00美元，净利润-12.26百万美元，每股收益-0.17美元，毛利-460000.00美元，市盈率-1.13倍。机构评级方面，在所有2家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Cue Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.19%。其相关个股中，Zyversa Therapeutics, Inc.、Rallybio Corporation、Seastar Medical Holding Corporation涨幅较大，Zyversa Therapeutics, Inc.、Moleculin Biotech, Inc.、Rallybio Corporation较为活跃，换手率分别为2051.25%、558.05%、304.18%，振幅较大的相关个股有Zyversa Therapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 (To Pur Com)、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 (To Pur Com)，振幅分别为87.67%、73.34%、70.96%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段的生物制药公司。该公司正在开发一类新型专有生物制剂药物，用于选择性调节人体免疫系统，以治疗多种癌症和自身免疫性疾病。其目标是通过生物候选药物产品平台为癌症和自身免疫性疾病患者提供显著改善的治疗效果。正在筹备中的其他产品包括 CUE-101 作为单一疗法、CUE-101 Pembrolizumab、CUE-102、CUE-103 等。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2549529294","isCrawlerRequest":true}

Cue Biopharma, Inc.盘中异动 急速上涨5.04%

精彩评论

Cue Biopharma, Inc.盘中异动急速上涨5.04%